|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Wyeth |
|---|---|
| Information provided by: | Wyeth |
| ClinicalTrials.gov Identifier: | NCT00434486 |
Purpose
To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.
| Condition | Intervention | Phase |
|---|---|---|
|
Healthy |
Drug: SKI-606 |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment, Pharmacokinetics Study |
| Official Title: | An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 Administered Orally to Healthy Subjects |
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | 3160A4-104 |
| Study First Received: | February 9, 2007 |
| Last Updated: | September 10, 2007 |
| ClinicalTrials.gov Identifier: | NCT00434486 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Anti-Infective Agents Therapeutic Uses Antifungal Agents Ketoconazole Pharmacologic Actions |